ARTICLE | Clinical News
Ferriprox deferiprone regulatory update
September 19, 2011 7:00 AM UTC
FDA's Oncologic Drugs Advisory Committee voted 10-2 that Ferriprox deferiprone has a favorable benefit-risk profile to treat transfusional iron overload when current chelation therapy is inadequate. T...